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The source of TGF-b, which regulates inflammation in various disease settings, is unclear. In this
issue of Immunity, Li et al. (2007) find that not only does T cell-produced TGF-b regulate Th1-cell-
mediated inflammation, but it is also required for the generation of Th17 cells in vivo.Transforming growth factor-b (TGF-b)
has long been recognized for its immu-
noregulatory functions in controlling
inflammation. Mice carrying a Tgfb1
null mutation suffer severe inflamma-
tory disease leading to early death;
this disease phenotype is partly asso-
ciated with the dependence of Foxp3+
regulatory T (Treg) cells on TGF-b
signaling for their maintenance in the
periphery. TGF-b production by Treg
cells has also been suggested as an
important (if controversial) mechanism
of suppression. Recently, TGF-b has
been in the spotlight because of its
emerging roles in the differentiation of
both inducible Foxp3+ Treg cells and
RORgt+ T helper 17 (Th17) cells from
naive T cells (Bettelli et al., 2006;
Ivanov et al., 2006), with interleukin-2
(IL-2) and IL-6 acting as switch factors
between Treg and Th17 cells, respec-
tively (Bettelli et al., 2006; Laurence
et al., 2007) (Figure 1). The potential
cellular sources of TGF-b in vivo are
many, and in the current issue of
Immunity, Li et al. (2007) have used
mice with a CD4+ T cell-specific dele-
tion of TGF-b1 to investigate the con-
tribution of T cell-produced TGF-b to
the maintenance of tolerance anddevelopment of autoreactive T cells
in vivo.
Li et al. (2007) find that mice with T
cell-specific deletion of TGF-b1 devel-
oped a similar wasting disease to
that observed in TGF-b1 complete-
knockout mice and T cell-restricted
TGF-bRII knockout mice: multiorgan
leukocyte infiltration, autoantibody
production, and early lethality. How-
ever, because the phenotype is less
severe and disease onset substantially
delayed, T cells are not the only source
of TGF-b that regulates peripheral
tolerance.
Unlike TGF-b1-deficient mice, the
numbers of peripheral Treg cells are
normal or increased in mice with a T
cell-specific deletion of TGF-b. The
inflammatory disease manifested in
these mice therefore could not be at-
tributed to a lack of Treg cells per se.
However, it was unclear whether the
disease regulation was mediated by
Foxp3+ Treg cells or naive Foxp3
T cells because both were observed
to produce TGF-b after T cell-receptor
ligation. Thus, the authors investigated
the relative contributions of Foxp3+
and Foxp3 cells in the T cell transfer
model of colitis, in which Treg-cell-Immunmediated suppression of inflammation
is dependent on functional TGF-bRII
signaling in naive T cells. In this model,
Treg-cell production of paracrine TGF-
b was found to be crucial for control of
colitis, whereas naive T cells provide
a very minor contribution. Previous
studies had purified Treg cells on the
basis of CD25 expression—also a
marker of activated T cells—which
may have confounded the results.
The distinct advantage of the current
study was the purification of Treg cells
on the basis of Foxp3 expression, thus
eliminating contamination from acti-
vated T cells and clearly demonstrat-
ing an essential role for Treg cell
production of TGF-b.
One of the most striking findings of
this study is the clear dichotomy in
the generation of effector T helper sub-
sets: T cell-specific deletion of TGF-b
resulted in increased frequencies of
Th1 and Th2 cells but a decrease in
the frequency of Th17 cells. This re-
vealed two important points. First, the
multiorgan inflammatory disease and
colitis observed in these mice are pre-
dominantly mediated by Th1 cells and
do not require the generation of Th17
cells. Second, T cells themselves areity 26, May 2007 ª2007 Elsevier Inc. 547
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PreviewsFigure 1. Proposed T Cell Lineage Development and Functional Pathways
TCR activation of naive T cells will induce a range of positive and negative autocrine and paracrine
signals for lineage commitment. IFN-g and IL-4 serve as positive signals for Th1- and Th2-cell
induction of T-bet and GATA-3, respectively. Conversely, T cell production of TGF-b limits Th1
and Th2 responses while providing a critical signal for the generation of inducible Treg and
Th17 cells. Treg cells could be a source of TGF-b. IL-2 and IL-6 serve as switch factors for
Treg- and Th17-cell development, respectively.a primary source of TGF-b for the line-
age commitment of Th17 cells in vivo
(Figure 1). Several studies have re-
cently shown that Th17 cell differentia-
tion is dependent on TGF-b signaling
in the presence of inflammatory cyto-
kines (Veldhoen et al., 2006; Bettelli
et al., 2006;Mangan et al., 2006). How-
ever, the physiological sources of
TGF-b in this process were not clear.
Veldhoen et al. (2006) found Treg cells
to be sufficient sources of TGF-b for
Th17 induction in the presence of
lipopolysaccharide in vitro, although
it seemed likely that dendritic cells
would also contribute in vivo. It is
therefore surprising that T cell-pro-
duced TGF-b played such a dominant
role in Th17 differentiation, and again
raises the controversial question: do
Foxp3+ Treg cells actually promote
pathogenic Th17 cell generation
in vivo? Because both naive Foxp3548 Immunity 26, May 2007 ª2007 Elseand Foxp3+ T cells can produce
TGF-b after activation, the T cell
source of TGF-b for Th17 generation
in vivo was not identified in this study.
The generation of mice with the dele-
tion of TGF-b restricted to Foxp3+ T
cells will most likely resolve this issue.
Since the discovery that IL-17-pro-
ducing T cells can induce autoimmune
inflammation, there has been intense
interest to understand the relative
contributions of Th17 and Th1 cells
in disease pathogenesis. Using the T
cell-specific TGF-b-deficient mice, Li
et al. (2007) showed that the major
pathogenic population generated dur-
ing the establishment of colitis is Th1
cells. This has also been reported in
two recent studies investigating the
relative roles of IL-12, IL-23, inter-
feron-g (IFN-g), and IL-17 in a naive
CD4+ T cell transfer model as well as
in Helicobacter-induced colitis (Huevier Inc.et al., 2006; Kullberg et al., 2006). In
these models IFN-g, but not IL-17,
was the crucial T cell effector cytokine
when Treg cells were absent, whereas
a mixture of Th17 and Th1 cells was
observed to be important when colitis
was induced by blocking of IL-10R.
However, IL-23 rather than IL-12 is es-
sential for establishment of intestinal
inflammation in all of these models,
as well as in a T cell-independent-
colitis model (Uhlig et al., 2006). These
observations are further supported by
the recent identification of IL-23R as
a susceptibility gene in Crohn’s dis-
ease (Duerr et al., 2006). It seems likely
that IL-23 acts directly on innate im-
mune cells in the gut to promote
inflammation, although the targets of
IL-23 in Crohn’s remain to be iden-
tified. Likewise, the relative contri-
butions of Th1 and Th17 cells in human
inflammatory-bowel disease have yet
to be clarified. The current study did
not address the role, if any, of Treg-
cell-produced TGF-b on the innate
cells in the gut, but it would be intrigu-
ing to speculate that TGF-bmay regu-
late IL-23 production as part of the
anti-inflammatory process.
Although Th1 cells appear to be
crucial in intestinal inflammation that
occurs in the absence of TGF-b, Th17
cells do have a dominant pathogenic
role in other tissue organs. Li et al.
(2007) showed that when T cells were
unable to produce TGF-b, the resulting
impaired ability to generate Th17 cells
greatly reduced disease susceptibility
to experimental autoimmune enceph-
alomyelitis (EAE). A similar observation
wasmade inmicewith impaired TGF-b
signaling in T cells, which were also
resistant to Th17 induction and EAE.
These findings highlight the impor-
tance of Th17 cells rather than Th1
cells in driving inflammatory re-
sponses in the central nervous system.
It is interesting that inflammation in
different tissue sites appears to involve
different subsets of helper T cells: This
may be due to preferential migratory
properties of different helper T cell
subsets or to differences in how the
cells in each local environment re-
spond to effector cytokines such as
IL-17, IL-22, and IFN-g.
One final point worth considering is
the current effort to expand regulatory
Immunity
PreviewsT cells as a therapy for inflammatory
disorders. If Treg cells are actually
able to induce or expand pathogenic
Th17 cells in vivo, they may do more
harm than good in some situations. It
will be imperative to establish the role,
if any, of Treg cells in promoting inflam-
mation, and also to properly identify
which T helper cell subset predomi-
nates in different human disease set-
tings before attempting such therapy.
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